Driving after Concussion: Symptom Clusters and Neurocognition Uniquely Relate to Post-concussion Driving Performance
Abstract
PURPOSE: This study aimed to identify clinical concussion assessment outcomes that uniquely capture simulated driving performance among acutely concussed individuals, relative to controls.
METHODS: Cross-sectional design. Twenty-eight college students within 72 hours of concussion and 46 non-concussed controls participated in the study. We collected the following clinical concussion assessment outcomes: four concussion symptom clusters, seven computerized neurocognitive domain scores, Standardized Assessment of Concussion total score, Balance Error Scoring System total score, and tandem gait completion time. The following simulated driving outcomes were included (count): total collisions, speed exceedances, centerline crossings, and road edge excursions. We used separate generalized linear mixed regression models fit using a Poisson distribution with group, assessment, and interaction effects.
RESULTS: Higher migrainous symptoms ( P < 0.001), cognitive-fatigue symptoms ( P = 0.041), poorer visual memory ( P = 0.015), and slower reaction time ( P = 0.023) in concussion group were associated with higher risk of committing speed exceedances, relative to controls. Conversely, better performance on the continuous performance test ( P = 0.046) and Standardized Assessment of Concussion ( P = 0.045) in concussion group was associated with higher risk of committing speed exceedances relative to controls. Poorer performance on psychomotor speed ( P = 0.001), reaction time ( P =…
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.